Back to search

Sofosbuvir and Simeprevir Versus Sofosbuvir and Ribavirin in Treatment of HCV

NCT03069001

PHASE4INTERVENTIONAL
Ain Shams University
90 participants
Started 2015-06 · Completed 2016-03
Status: Completed (as of 12-23-2025)

Conditions

HCV

Interventions

DRUG: Sofosbuvir-SimeprevirDRUG: Sofosbuvir-Ribavirin

Linked Papers (from SciSciNet-V2)

Total Papers0
Background
0
Result
0
Derived
0
Unknown
0
View on ClinicalTrials.gov

Brief Summary

This prospective study was conducted at Ain Shams University Hospital, Internal Medicine, Hepatology and Gastroenterology Department, and Tropical Medicine Department. To compare the efficacy of the combination of sofosbuvir and simeprevir for 12 weeks with the combination of sofosbuvir and ribavirin for 24 weeks in Egyptian patients with HCV-related Child A cirrhosis.

No papers linked to this trial in SciSciNet

Visit ClinicalTrials.gov for more information about this study